13.41
+0.06(+0.45%)
Currency In CNY
Address
Everbright International Trade Center
Zhuhai, 519015
China
Phone
86 75 6388 2955
Website
Sector
Healthcare
Industry
Biotechnology
Employees
483
First IPO Date
September 13, 2017
| Name | Title | Pay | Year Born |
| Nan Gui Cai | Chairman & Chief Executive Officer | 0 | 1962 |
| Dai Feng Duan | Deputy General Manager | 0 | 1979 |
| Xing Wang | Deputy General Manager | 0 | 1983 |
| Dawen Liu | Deputy GM & Non-Independent Director | 0 | 1989 |
| Jian Feng Li | Deputy GM & Director | 0 | 1981 |
| Jing Gao | Financial Director | 0 | 1976 |
| Zhang Xu | Board Secretary, Deputy GM & Director | 0 | 1986 |
| Tangneng Qu | Accounting Supervisor | 0 | N/A |
Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, gaicycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, and pantoprazole sodium products. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proton pump inhibitors, anti-infectives, anti-bleeding medicine, analgesics, and other fields. The company was formerly known as Zhuhai Sailong Pharmaceutical Co.,Ltd. and changed its name to Sailong Pharmaceutical Group Co., Ltd. in September 2021. Sailong Pharmaceutical Group Co., Ltd. was founded in 2002 and is based in Zhuhai, China.